INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $691,000 | +232.2% | 149,729 | +151.6% | 0.00% | – |
| Q4 2018 | $208,000 | -79.2% | 59,500 | -40.0% | 0.00% | – |
| Q3 2018 | $1,000,000 | +3.0% | 99,200 | -26.0% | 0.00% | – |
| Q2 2018 | $971,000 | +7.2% | 134,100 | -10.6% | 0.00% | – |
| Q1 2018 | $906,000 | -61.4% | 150,078 | -38.5% | 0.00% | -100.0% |
| Q4 2017 | $2,347,000 | +7.6% | 244,046 | -0.7% | 0.00% | 0.0% |
| Q3 2017 | $2,182,000 | +21.0% | 245,746 | +72.4% | 0.00% | -50.0% |
| Q2 2017 | $1,803,000 | +13.9% | 142,508 | -5.4% | 0.00% | 0.0% |
| Q1 2017 | $1,583,000 | -19.6% | 150,598 | -29.7% | 0.00% | 0.0% |
| Q4 2016 | $1,970,000 | -67.4% | 214,086 | -58.2% | 0.00% | -66.7% |
| Q3 2016 | $6,035,000 | -52.8% | 511,883 | +14.7% | 0.01% | -57.1% |
| Q4 2015 | $12,773,000 | -53.6% | 446,129 | -53.8% | 0.01% | -46.2% |
| Q3 2015 | $27,505,000 | +285.0% | 966,417 | +385.8% | 0.03% | +333.3% |
| Q2 2015 | $7,144,000 | +68.5% | 198,913 | +172.6% | 0.01% | +50.0% |
| Q1 2015 | $4,241,000 | +635.0% | 72,958 | +432.4% | 0.00% | +300.0% |
| Q4 2014 | $577,000 | -36.4% | 13,703 | -41.4% | 0.00% | 0.0% |
| Q3 2014 | $907,000 | -10.6% | 23,396 | -28.0% | 0.00% | 0.0% |
| Q2 2014 | $1,015,000 | +33.6% | 32,511 | +77.4% | 0.00% | 0.0% |
| Q1 2014 | $760,000 | -43.3% | 18,326 | -47.1% | 0.00% | -50.0% |
| Q4 2013 | $1,341,000 | +331.2% | 34,635 | +289.6% | 0.00% | – |
| Q3 2013 | $311,000 | – | 8,891 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |